Douglas J. Rhee, MD

122APPENDIX 1. TOPICAL ANTIBACTERIAL SPECTRUM (continued)polymyxin poly/ tetra/baci cephazolin CAM cipro erythro gati gent levo moxi norflox oflox B trimeth sulfa poly tobra vancoMoraxella species o + + + o + o + + o + o o o o o oNeisseria species + + + + + + + + + + + o o o o + iPseud. aeruginosa o o + + o + + + + o + i i i + + oPseud aeruginosa FR ? ? ? − ? − ? − − − − ? ? ? ? ? ?Serratia marcescens o o + + o + + + + o + o + o o + oAeromonas o o i + o + + + + + + o o o o o oAcinetobacter + o o + o + + + + + + i o o o + oBacteroides fragilis o o + o o + o + + o + o o o o o oProprionobacter acnes o o o o i o o o o o i o +Table compiled from information from Physicians’ Desk Reference for Ophthalmology, 2nd ed. Montvale, NJ: Medical Economics, 1999; Sanford JP, Gilbert,DN, Sande MA. Sanford Guide to Antimicrobial Therapy. Dallas: Antimicrobial Therapy, Inc., 1995; Gilman, AG, Rall, TW. Nies, AS, Taylor P. Goodman andGilman’s The Pharmacological Basis of Therapeutics, 8th ed. Oxford: Pergamon Press, 1990; Murray PR, Baron EJ, Pfaller, MA, Tenover FC, Yoken, RH.Manual of Clinical Microbiology, 6th ed. Washington, DC: American soceity for Microbiology press, 1995; Graves A et al. Cornea 2001;3:301–305; KowalskiRP et al. Am J Ophthalmol 2003;136:500–505; Hwang DG. Surv Ophthalmol 2004;49:S79–S83; Mather R et al. Am J Ophthalmol 2002;133:463–466; FiscellaRG et al. Ophthalmology 1999;106:2286–2290.